Heart drug for blacks priced according to patient's income

07/8/2005 | NYTimes.com

NitroMed has provoked controversy with a pricing plan for its recently approved heart drug for blacks. The basic price per pill is higher than expected, analysts say, but the company also is offering steep discounts for poor or uninsured patients, meaning the drug is priced according to patients' wealth.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN